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A B S T R A C T
Papillary thyroid carcinoma (PTC) is the most common malignant thyroid disease characterized by a high rate of cer-
vical metastases (30–80%), especially due to paratracheal lymph node involvement. »Skip metastasis« are defined as a
lateral lymph node metastasis without central lymph node involvement. The aim of this prospective study was to estab-
lish the lateral nodal metastasis pattern according to neck level, general occurrence and significance of skip metastasis
in PTC. Forty-two previously untreated patients who presented between 2007 and 2011 with concomitant diagnosis of
papillary thyroid cancer and metastatic disease of the lateral neck, underwent total thyroidectomy and central and lat-
eral neck dissection. Skip metastases were encountered in 8(19.5%) patients, four female and four male, with a mean age
of 43.3 years. In all patients with lateral skip metastasis, level III nodes were most frequently involved (75%) followed by
level IV(50%), while no metastatic disease was found in level IIb. Based on our research, skip metastasis are not uncom-
mon (a lateral lymph node metastasis without central lymph node involvement) and present in approximately 1/5 of PTC
patients with cervical lymph node metastasis.
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Introduction
Papillary thyroid carcinoma (PTC) is the most com-
mon form of thyroid gland malignancy with a tendency of
lymphatic spread. Lymph node metastases develop in ap-
proximately 30–80% of PTC patients1–3. Clinicopatho-
logical investigations have revealed that dissemination of
tumor cells through the lymphatic system evolves in a
stepwise sequential fashion: spreading from the thyroid
gland, the central (pre- and paratracheal nodes and up-
per mediastinal) and lateral (levels II–V) lymph node
compartments on the side of the thyroid tumor represent
the first level of lymphatic drainage, followed by opposite
lateral and the mediastinal lymph node compartments4.
»Skip metastasis« are defined as a lateral lymph node
metastasis without central lymph node involvement. The
incidence of skip metastasis in PTC is reported to be
about 2–38%5–7 The aim of this prospective study was to
establish the lateral nodal metastasis pattern according
to neck level, general occurrence and significance of skip
metastasis in PTC.
Methods
This prospective study included 42 previously un-
treated patients who presented between 2007. and 2011.
with concomitant diagnosis of papillary thyroid cancer
and metastatic disease of the lateral neck. All patients
preoperatively underwent ultrasonography. Diagnosis of
primary tumor and lymph node metastasis has been con-
firmed by fine-needle aspiration cytology (FNAC). Thy-
roidectomy and neck dissection specimens were histolo-
gically examinated. All surgical procedures were carried
out by a single surgeon. Excluded were patients with any
previous treatment of the thyroid gland and/or neck (in-
cluding irradiation). All patients underwent total thy-
roidectomy and therapeutic neck dissection of both cen-
tral and lateral compartments. Bilateral lateral neck
dissection was carried out in six patients.
The central compartment dissection included four
nodal sublevels: pretracheal, both ipsilateral and contra-
lateral paratracheal and superior mediastinal below the
sternal notch. In all patients complete removal of lateral
cervical lymph nodes was performed (levels II to V)8,9.
The neck levels, sublevels (IIa and IIb, respectively) and
central nodal sublevels were marked and sent for his-
tological examination. Sublevel IIb contents were always
processed as a separate specimen. A diagnosis of skip me-
tastasis was made exclusively after histological confirma-
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tion of nodal metastasis in the lateral neck, leaping the
central lymph node compartment.
Results
The study group of 42 patients underwent total thy-
roidectomy and therapeutic neck dissection (both central
and lateral). Bilateral lateral neck dissection was carried
out in six patients. One patient was excluded from the
study based on false positive FNAC, showing no metasta-
sis disease in lymph nodes following histological exami-
nation; therefore the final number of analyzed patients
was 41.
The main observation of this prospective study was
group of patients with skip lateral metastasis and no
metastatic involvement of central lymph nodes. Skip
metastases were encountered in eight (19.5%) patients,
four female and four male, with a mean age of 43.3 years.
No single patient from this group had bilateral neck dis-
section. Ipsilateral lateral neck dissection was carried
out in seven (87.5%) patients and contralateral lateral
neck dissection in one patient.
Primary tumor was in right thyroid lobe in four, in
left thyroid lobe in three patients, while one patient pre-
sented with primary tumor in both thyroid lobes.
Assessment of the primary tumor stage revealed T1
lesions in one patient, T2 in one patient and T3 tumor in
six patients (75%). Multicentric lesions were found in six
(75%) and extrathyroid spread in five patients (62.5%),
respectively.
Out of eight lateral neck dissection tissues, six pa-
tients (75%) showed nodal disease at multiple levels and
two had single level disease. Out of latter two specimens
with single level disease, one had metastatic disease in
level II and one in level IV. In all patients with lateral
skip metastasis, level III nodes were most frequently in-
volved (75%) followed by level IV(50%), while no meta-
static disease was found in level IIb. Level V involvement
was always associated with multiple level disease (Figure
1).
In all lateral neck dissection specimens, 263 lymph
nodes were observed and 41 were found positive (Figure
2). In four patients (50%) extracapsular spread was found
(total of 10 metastatic lymph nodes). In one patient
extracapsular spread in two metastatic levels (III and IV)
was observed.
Discussion
This prospective study comprised eight patients with
skip lateral metastasis, singled out from very homoge-
nous group of 41 previously untreated patient, presented
with concomitant diagnosis of PTC and metastatic dis-
ease of the lateral neck. All patients underwent total
thyroidectomy and a comprehensive central and lateral
neck dissection in an uniform fashion by a single sur-
geon.
Lymph node metastases develop in approximately
30–80% of papillary thyroid carcinoma patients1-3. Cervi-
cal metastases occur first to the nodes in the tracheoeso-
phageal groove and subsequently in the lateral neck1,10.
Skip metastasis with its erratic mode of lymphatic spread
(a lateral lymph node metastasis without central lymph
node involvement), are a genuine phenomenon of low-in-
tensity nodal dissemination in thyroid cancer11. The inci-
dence of skip metastasis in previous studies was shown
to be between 2–38%5–7. According to our study occur-
rence of skip metastasis was relatively high (19.5%), sim-
ilar to one reported in a previous study by Pinkpank et
al.7. Byung-Joo Lee et al. believe that high rate of skip
metastases can be explained by including patients with
previous neck treatment (total thyroidectomy or lateral
cervical surgery)12. However, according to our study
which included only previously untreated patients, this
hypothesis was refuted. Ultrasonography and FNAC of
primary tumor and lymph node metastasis have proved
to be valid preoperative diagnostic procedures. Hwang
HS et al. and Joon Y et al. in their recent work concur
that preoperative neck ultrasonography due to it’s high
sensitive and specific nature in predicting cervical lymph
node metastasis provides reliable information to assist in
surgical management of PTC patients13,14. On the other
side, this was opposed by Imidat Yuce et al. who sug-
gested routine computed tomography (CT) evaluation for
all patients with palpable jugular lymph node metastasis
because retropharygeal metastases will be missed by rou-
tine ultrasonography15. Regarding the high occurrence of
central and lateral lymph node metastasis and on the
other hand rare presence of retropharyngeal metastasis
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Fig. 1. Percenage of lateral neck involvement: level IIa (20.27%),
level IIb (0%), level III (32.63%), level IV (11.84%), level V (4.08%).
Fig. 2. Total number of isolated lymph nodes in eight patients
(total thyroidectomy and lateral neck disection) from level IIa-V
was 263, and number of positive metastatic lymph nodes in late-
ral neck level (IIa-V) was 41.
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in PTC patients, we believe CT takes role in patient fol-
low up especially in the setting of recurrent disease.
In the present study, the lateral nodal metastasis pat-
tern according to neck level was similar to that reported
previously and first described by Sivanadan and Soo et
al. The majority of patients presented with multiple-level
metastasis. The nodal groups of levels II, III and IV were
found to be at greatest risk of metastatic disease, with
level III nodes being the most frequently involved. The
results of this study correspond with the results of previ-
ous studies7,9,10,12,15–22. However, Ducci et al. and Roh JL
at al, reported that level IV nodes are the most frequent
metastatic lymph nodes5,23.
Neck dissection of the lymph node at level IIb in PTC
is associated with the risk of spinal accessory nerve in-
jury, despite preservation, resulting from traction and el-
evation during removal of metastatic lymph nodes. The-
refore, it is essential to investigate the incidence of level
IIb lymph node metastasis in patients with lateral cervi-
cal matastatic lymph node in PTC12. In our prospective
study in all revised lateral neck dissection specimens, in
level IIb no metastatic disease was found. This findings
were slightly different from those of prior studies20,21. Al-
though mentioned authors also found level IIb to be the
least represented site of metastatic disease, at least a
small percentage (7–21%) of positive lymph nodes was
found. In the future we plan to establish whether neck
dissection of the lymph node at level IIb is necessary in
patients if level IIa is uninvolved.
Conclusion
Based on our research, skip metastasis are not un-
common (a lateral lymph node metastasis without cen-
tral lymph node involvement) and present in approxi-
mately 1/5 of PTC patients with cervical lymph node
metastasis. Ultrasonography and FNAC of primary tu-
mor and lymph node metastasis have proved to be valid
preoperative diagnostic procedures. Most patients had
multilevel nodal involvement at the time metastatic dis-
ease was found.
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SKIP METASTAZE KOD PAPILARNOG KARCINOMA [TITNJA^E
S A @ E T A K
Papilarni karcinom {titnja~e (PTC) je naj~e{}a maligna bolest {titnja~e, karakterizirana visokom stopom vratnih
metastaza (30-80%), osobito zbog uloge paratrahealnih limfnih ~vorova. »Skip metastaze« su definirane kao metastaze
u lateralnim regijama vrata, bez zahva}enosti sredi{njih limfnih ~vorova. Cilj ove prospektivne studije bilo je utvrditi
karakteristike metastaza u lateralne regije vrata kod PTC, u~estalost pojave skip metastaza i njihov zna~aj. Kod ~etr-
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deset i dva prethodno nelije~ena pacijenta izme|u 2007. i 2011. sa istodobnom dijagnozom papilarnog karcinoma {tit-
nja~e i metastaze u lateralnim regijama vrata, u~injena je totalna tireoidektomija, te centralna i lateralna disekcija
vrata. Skip metastaze su dokazane u 8 (19,5%) bolesnika, ~etiri `ene i ~etiri mu{karca, s prosje~nom dobi od 43,3
godina. U svih bolesnika sa lateralnim metastazama, naju~estalija regija metastaziranja je bila regija III (75%), zatim
regija IV (50%), dok u regiji IIb nije prona|ena metastatska bolest. Na temelju na{ih istra`ivanja, skip metastaze nisu
rijetkost (metastaze u lateralnim limfnim ~vorovima bez zahva}enosti sredi{njih limfnih ~vorova) i prisutne su u oko
1/5 od PTC bolesnika.
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